Monopolistic Pricing Power for Transgenic Crops When Technology Adopters Face Irreversible Benefits and Costs

Posted: 19 Aug 2008

See all articles by Robert D. Weaver

Robert D. Weaver

Pennsylvania State University - Operations Research Faculty; College of Agricultural Sciences, Department of Agricultural Economics and Rural Sociology

Multiple version iconThere are 2 versions of this paper

Date Written: August, 18 2008

Abstract

Pricing of biotechnology innovation under a patent grant is reconsidered in a model with uncertain returns and irreversible costs and benefits. Past results on restricted monopoly pricing in the presence of competing technologies showed that pricing power is reduced. The timing of adoption of an innovation is delayed and the pricing power of the restricted monopolist is further reduced when uncertainty and irreversibility is considered. The presence of irreversible benefits results in increased willingness-to-pay for the innovation, accelerating adoption, and increasing the innovator's restricted monopolist pricing power. Using Monte-Carlo simulation, the quantitative effects were approximated by a linear function through the hyper-plane.

Suggested Citation

Weaver, Robert D., Monopolistic Pricing Power for Transgenic Crops When Technology Adopters Face Irreversible Benefits and Costs (August, 18 2008). Available at SSRN: https://ssrn.com/abstract=1234862

Robert D. Weaver (Contact Author)

Pennsylvania State University - Operations Research Faculty ( email )

University Park, PA 16802
United States

College of Agricultural Sciences, Department of Agricultural Economics and Rural Sociology ( email )

University Park, PA 16802-3306
United States

HOME PAGE: http://globalvaluechains.aers.psu.edu/

Here is the Coronavirus
related research on SSRN

Paper statistics

Abstract Views
203
PlumX Metrics